[北京美国中心] 宫颈癌以及HPV 疫苗小组讨论
为支持 2024 年宫颈癌消除行动日，美国驻华大使馆和澳大利亚驻华大使馆将举办一场关于宫颈癌和 HPV 疫苗接种的活动。来自美国、澳大利亚和中国的嘉宾将分享他们的见解并回答观众的问题。主讲嘉宾为：
米歇尔·吉尔斯（Michelle Giles）教授
医学学士（荣誉学位）澳大利亚皇家内科医师学会院士（莫纳什大学）
澳大利亚免疫技术咨询小组（ATAGI）副主席
传染病医生和临床科学家
李碧菁（Roberta Lipson）女士
和睦家医疗 (UFH) 的创始人
新风医疗副主席
中国美国商会主席和美中贸易全国委员会主任
特德·特林布尔（Ted Trimble）医学博士
美国国立卫生研究院国家癌症研究所全球 HPV 和宫颈癌控制高级顾问
宫颈癌是全球女性中第四大常见癌症，2022 年全球约有 66 万例新发病例和 35 万例死亡病例。人乳头瘤病毒 (HPV) 是一种常见的性传播感染，几乎所有有性生活的人都会在一生中的某个时刻感染，通常没有症状。在大多数情况下，免疫系统会清除体内的 HPV。持续感染高危 HPV 会导致异常细胞发展，进而发展为癌症。宫颈癌可通过疫苗接种和筛查高度预防和治疗。阅读更多：https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
活动信息：
日期：2024 年 11 月 25 日
时间：18:00 – 19:30
地点：北京美国中心
请扫描二维码注册参加活动
重要提示：
• 请携带您的身份证件原件前往美国中心。
• 请勿携带笔记本电脑。
嘉宾介绍
米歇尔·吉尔斯 (Michelle Giles) 教授，医学学士（荣誉）澳大利亚皇家内科医师学会会员（FRACP）博士（莫纳什大学），是一名传染病医生和临床科学家，目前担任澳大利亚免疫技术咨询小组 (ATAGI) 副主席。ATAGI 为澳大利亚政府提供有关澳大利亚现有疫苗的医疗管理方面的建议，并就实施免疫政策、程序和疫苗安全向相关组织提供咨询。吉尔斯教授阿尔弗莱德医院、皇家妇女医院和莫纳什健康中心担任临床职务，并在墨尔本大学和莫纳什大学担任学术职务。她对孕妇免疫和妊娠期血源性病毒进行了广泛的研究，并发表了有关人乳头瘤病毒和人乳头瘤病毒疫苗的文章。
李碧菁（Roberta Lipson）女士是和睦家医疗 (UFH) 的创始人，也是新风医疗副主席、中国美国商会主席和美中贸易全国委员会主任。她在中国医疗行业拥有 40 多年的从业经验。李碧菁女士还创立并领导了联合中国健康基金会，这是一家非营利性组织，为医疗资源匮乏的人群提供挽救生命的干预措施和健康管理。该基金会率先开展了宫颈癌根除试点项目，包括每年直接服务数千名农村妇女的筛查和治疗任务，还培训当地医护人员以最有效的方法预防和治疗宫颈癌。
特德·特林布尔（Ted Trimble）医学博士是美国国立卫生研究院国家癌症研究所全球 HPV 和宫颈癌控制高级顾问。特林布尔博士是国际公认的宫颈癌、卵巢癌、子宫癌和其他妇科癌症预防、筛查、治疗和症状管理方面的专家。他领导了一项针对妇科癌症治疗试验的国家科学项目，并与世界各地的同事合作制定这些疾病的全球研究战略。
[Beijing American Center] Cervical Cancer and HPV vaccination Panel Discussion
In support of the Cervical Cancer Elimination Day of Action 2024, the U.S. Embassy in China and the Australian Embassy in China are hosting an in-person and virtual event on cervical cancer and HPV vaccination. Panelists from the U.S., Australia, and China will share their insights and answer audience questions. Guest speakers include:
Professor Michelle Giles
MBBS (Hons) FRACP PhD (Monash)
Deputy Chair of the Australian Technical Advisory Group on Immunisation (ATAGI)
Infectious Disease Physician and Clinician Scientist
Ms. Roberta Lipson
Founder of United Family Healthcare (UFH)
Vice Chair of New Frontier Health
Chair of AmCham China and Director of the U.S.-China Business Council
Dr. Ted Trimble
Senior Advisor for Global HPV and Cervical Cancer Control at the National Cancer Institute, National Institutes of Health
Globally, cervical cancer is the fourth most common cancer in women, with approximately 660,000 new cases and 350,000 deaths worldwide in 2022. Human papillomavirus (HPV) is a common sexually transmitted infection and almost all sexually active people will be infected at some point in their lives, usually without symptoms. In most cases the immune system clears HPV from the body. Persistent infection with high-risk HPV can cause abnormal cells to develop, which go on to become cancer. Cervical cancer is highly preventable and treatable through vaccination and screening. Read more: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
Event Information:
Date: November 25, 2024
Time: 18:00 – 19:30
Location: Beijing American Center
Please scan the QR code to register for the event.
Speakers’ Bio
Professor Michelle Giles MBBS (Hons) FRACP PhD (Monash) is an infectious disease physician and clinician scientist who is currently Deputy Chair of the Australian Technical Advisory Group on Immunisation (ATAGI). ATAGI advises the Australian Government on the medical administration of vaccines available in Australia, and consults with relevant organisations in implementing immunisation policies, procedures and vaccine safety. Professor Giles has clinical appointments at Alfred Health, The Royal Women’s Hospital and Monash Health and academic appointments at the University of Melbourne and Monash University. She has conducted extensive research on maternal immunisation and bloodborne viruses in pregnancy and has published articles on the Human Papillomavirus and the Human Papillomavirus Vaccine.
Roberta Lipson is the founder of United Family Healthcare (UFH) and the Vice Chair of New Frontier Health, Chair of AmCham China and Director of the U.S.-China Business Council. She has over 40 years of experience as a pioneer in the healthcare industry in China. Ms. Lipson also founded and leads the United Foundation for China’s Health, a not-for-profit providing lifesaving interventions and health management for underserved populations. The Foundation has spear-headed pilot programs in cervical cancer eradication, including screen and treat missions directly serving thousands of rural women per year, but also training local healthcare workers in the most effective approaches to preventing and treating cervical cancer.
Dr. Ted Trimble MD, MPH is the Senior Advisor for Global HPV and Cervical Cancer Control at the National Cancer Institute, National Institutes of Health. Dr. Trimble has been recognized internationally as an expert in prevention, screening, treatment and symptom management for women with cervical, ovarian, uterine and other gynecologic cancers. He has led a national scientific program of treatment trials for gynecologic cancers and worked with colleagues worldwide to develop global research strategies for these diseases.
